Understanding Calcified Aortic Valve, also known as Aortic Valve Calcification, is crucial for accurate clinical documentation and medical coding. This page provides information on Aortic Stenosis due to Calcification, including diagnosis, symptoms, and treatment options. Learn about the connection between aortic valve calcification and aortic stenosis, and find resources for healthcare professionals related to coding and documentation for this cardiac condition.
Calcium buildup on the aortic valve, hindering blood flow from the heart.
Shortness of breath, chest pain, dizziness, fainting, heart murmur.
Cardiology clinic, echocardiography lab, cardiac catheterization lab.
Complete code families applicable to I35.8
| Description | When to use |
|---|---|
| Calcified aortic valve restricts blood flow. | Use when aortic valve calcification causes stenosis or impairs function. Consider severity. |
| Aortic stenosis without calcification. | Use for congenital bicuspid aortic valve or rheumatic aortic stenosis. Exclude calcification. |
| Aortic sclerosis: valve thickening without stenosis. | Use for early aortic valve thickening due to age or other factors. No significant obstruction. |
Coding aortic valve calcification without specifying mild, moderate, or severe stenosis impacts reimbursement and quality metrics.
Miscoding congenital vs. acquired aortic stenosis leads to inaccurate data reporting and potential clinical pathway errors.
Failing to document and code associated conditions like hypertension or heart failure impacts risk adjustment and resource allocation.
1. Auscultate for aortic stenosis murmur (ICD-10 I35.0)
2. Echocardiogram confirms calcification (CPT 76604)
3. Assess symptoms: dyspnea, chest pain, syncope
4. Review patient history for risk factors (e.g., age, hypertension)
5. Document severity & plan (e.g., meds, valve replacement)
Patient presents with symptoms suggestive of calcified aortic valve disease, including exertional dyspnea, angina, and syncope. Physical examination reveals a harsh systolic murmur radiating to the carotid arteries. The patient's medical history includes hypertension and hyperlipidemia, both risk factors for aortic valve calcification. Echocardiography confirms the diagnosis of calcified aortic valve, demonstrating significant aortic valve stenosis with reduced valve area and elevated transvalvular velocity. Aortic valve sclerosis, a precursor to stenosis, was considered in the differential diagnosis. The patient's symptoms, combined with the echocardiographic findings, meet the diagnostic criteria for severe aortic stenosis. Treatment options, including aortic valve replacement (AVR) surgery, transcatheter aortic valve replacement (TAVR), and medical management, were discussed with the patient. The risks and benefits of each approach, including potential complications such as bleeding, infection, and stroke, were explained. A cardiology consultation was obtained for further evaluation and management recommendations. The patient's current condition is stable, and they will be closely monitored for disease progression. ICD-10 code I35.0 (Aortic valve stenosis) is assigned. This diagnosis impacts medical billing and coding due to the complexity of the procedures involved in treatment, such as TAVR or AVR. Continued monitoring and optimization of medical therapy will be necessary to address the patient's aortic stenosis secondary to calcification.
Accurately staging calcified aortic valve disease is crucial for determining appropriate management strategies, especially in older adults. While echocardiography remains the primary imaging modality for initial assessment and can often distinguish between mild, moderate, and severe aortic stenosis, additional imaging may be necessary for complex cases. Cardiac computed tomography (CT) offers excellent visualization of aortic valve calcification and can quantify calcium burden, aiding in risk stratification. In cases where echocardiographic findings are equivocal, particularly in patients with low-flow, low-gradient aortic stenosis, cardiac CT can help differentiate true severe stenosis from pseudo-severe stenosis. Consider implementing a multi-modality imaging approach using both echocardiography and cardiac CT to enhance diagnostic accuracy in challenging cases. Explore how advanced imaging techniques can improve risk stratification and guide treatment decisions for calcified aortic valve disease in older adults.
Managing asymptomatic severe calcified aortic valve stenosis requires careful monitoring and shared decision-making with the patient. Current guidelines recommend watchful waiting with regular follow-up, including echocardiography and clinical evaluation, for truly asymptomatic patients. However, it's essential to distinguish between truly asymptomatic and patients experiencing subtle symptoms often overlooked or attributed to other conditions. Thorough patient history and assessment for symptoms like exertional dyspnea, syncope, or angina are crucial. Explore the latest guidelines from organizations like the American College of Cardiology (ACC) and the American Heart Association (AHA) regarding appropriate monitoring intervals and criteria for intervention in asymptomatic severe aortic stenosis. Consider implementing a structured follow-up plan and educating patients about potential symptom progression. Learn more about the evolving landscape of transcatheter aortic valve replacement (TAVR) and its role in managing this patient population.
Choosing between SAVR and TAVR for severe, symptomatic calcified aortic valve disease requires a multidisciplinary heart team approach, considering individual patient factors and risk profiles. While SAVR has been the traditional gold standard, TAVR has emerged as a less invasive alternative, particularly for higher-risk patients. Factors influencing the decision include age, frailty, surgical risk, presence of comorbidities, and anatomical suitability for TAVR. Explore the latest clinical trial data comparing SAVR and TAVR outcomes, considering factors like mortality, stroke risk, paravalvular leak, and valve durability. Consider implementing a shared decision-making process, involving the patient and their family in weighing the benefits and risks of each procedure. Learn more about patient selection criteria and procedural details for both SAVR and TAVR to ensure optimal patient outcomes in the context of calcified aortic valve disease.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.